Cargando…

What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?

Chronic inflammatory enteropathies in dogs are characterized by persistent or recurrent gastrointestinal signs that last for more than 3 weeks. Despite unclear etiopathogenesis, it is considered that a genetic predisposition associated with environmental factors, such as dietary antigens and intesti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacoor, Carina, Barros, Luís Meireles, Montezinho, Liliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of Veterinary Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830176/
https://www.ncbi.nlm.nih.gov/pubmed/33614437
http://dx.doi.org/10.4314/ovj.v10i4.9
_version_ 1783641347738042368
author Sacoor, Carina
Barros, Luís Meireles
Montezinho, Liliana
author_facet Sacoor, Carina
Barros, Luís Meireles
Montezinho, Liliana
author_sort Sacoor, Carina
collection PubMed
description Chronic inflammatory enteropathies in dogs are characterized by persistent or recurrent gastrointestinal signs that last for more than 3 weeks. Despite unclear etiopathogenesis, it is considered that a genetic predisposition associated with environmental factors, such as dietary antigens and intestinal microbiota, might induce an abnormal immune response in the host. The diagnosis of this condition requires full investigation in order to exclude all other possible causes. Currently, the observation of clinical signs associated with histopathologic evaluation and systematic therapeutic trials is the gold standard for the diagnosis of chronic enteropathies. Furthermore, diagnosis, monitoring the disease progression, and treatment response evaluation can be exhausting, since this whole process is time-consuming, costly, and partially invasive. Therefore, biomarkers appear as non-invasive tools, which can be useful in evaluating gastrointestinal function, identifying the presence of the disease and assessing its natural progression, monitoring gastrointestinal inflammation, predicting response to treatment, and clinical outcomes. Over the past decade, several studies were conducted in order to explore the clinical utility of biomarkers. Thus, the aim of this dissertation is to provide an overview of the biomarkers considered relevant in the diagnosis and management of dogs with chronic inflammatory enteropathies. The biomarkers addressed in this study may be serological, present in urine and feces, or even tissue-derived. This study argues that biomarkers, in particular calprotectin and calgranulin C, have great potential to be used in clinical practice in the diagnosis and management of affected dogs. However, a single biomarker cannot assuredly predict disease severity, progression, response to treatment, and clinical outcomes. Therefore, in order to achieve greater accuracy, it would be beneficial if these tools are used in conjunction with contemporary ones. Future research is needed with the aim to better determine the usefulness of these tools in chronic inflammatory enteropathies in dogs.
format Online
Article
Text
id pubmed-7830176
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Faculty of Veterinary Medicine
record_format MEDLINE/PubMed
spelling pubmed-78301762021-02-19 What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies? Sacoor, Carina Barros, Luís Meireles Montezinho, Liliana Open Vet J Review Article Chronic inflammatory enteropathies in dogs are characterized by persistent or recurrent gastrointestinal signs that last for more than 3 weeks. Despite unclear etiopathogenesis, it is considered that a genetic predisposition associated with environmental factors, such as dietary antigens and intestinal microbiota, might induce an abnormal immune response in the host. The diagnosis of this condition requires full investigation in order to exclude all other possible causes. Currently, the observation of clinical signs associated with histopathologic evaluation and systematic therapeutic trials is the gold standard for the diagnosis of chronic enteropathies. Furthermore, diagnosis, monitoring the disease progression, and treatment response evaluation can be exhausting, since this whole process is time-consuming, costly, and partially invasive. Therefore, biomarkers appear as non-invasive tools, which can be useful in evaluating gastrointestinal function, identifying the presence of the disease and assessing its natural progression, monitoring gastrointestinal inflammation, predicting response to treatment, and clinical outcomes. Over the past decade, several studies were conducted in order to explore the clinical utility of biomarkers. Thus, the aim of this dissertation is to provide an overview of the biomarkers considered relevant in the diagnosis and management of dogs with chronic inflammatory enteropathies. The biomarkers addressed in this study may be serological, present in urine and feces, or even tissue-derived. This study argues that biomarkers, in particular calprotectin and calgranulin C, have great potential to be used in clinical practice in the diagnosis and management of affected dogs. However, a single biomarker cannot assuredly predict disease severity, progression, response to treatment, and clinical outcomes. Therefore, in order to achieve greater accuracy, it would be beneficial if these tools are used in conjunction with contemporary ones. Future research is needed with the aim to better determine the usefulness of these tools in chronic inflammatory enteropathies in dogs. Faculty of Veterinary Medicine 2020 2020-11-27 /pmc/articles/PMC7830176/ /pubmed/33614437 http://dx.doi.org/10.4314/ovj.v10i4.9 Text en http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sacoor, Carina
Barros, Luís Meireles
Montezinho, Liliana
What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
title What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
title_full What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
title_fullStr What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
title_full_unstemmed What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
title_short What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
title_sort what are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830176/
https://www.ncbi.nlm.nih.gov/pubmed/33614437
http://dx.doi.org/10.4314/ovj.v10i4.9
work_keys_str_mv AT sacoorcarina whatarethepotentialbiomarkersthatshouldbeconsideredindiagnosingandmanagingcaninechronicinflammatoryenteropathies
AT barrosluismeireles whatarethepotentialbiomarkersthatshouldbeconsideredindiagnosingandmanagingcaninechronicinflammatoryenteropathies
AT montezinholiliana whatarethepotentialbiomarkersthatshouldbeconsideredindiagnosingandmanagingcaninechronicinflammatoryenteropathies